USE OF AT LEAST ONE FORM OF THE β2-GLYCOPROTEIN I AS AN ANTI-INFECTIOUS AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

摘要

Use of the β2-glycoprotein I, in at least one of its forms, for producing an anti-infectious agent for treating infectious diseases and capable of in vitro and in vivo activity. Used in vivo, it provides an anti-infectious drug for the medical treatment of animals or humans.